» Articles » PMID: 23741186

An Easy and Efficient Strategy for KEL Genotyping in a Multiethnic Population

Abstract

Background: The Kell blood group system expresses high and low frequency antigens with the most important in relation to transfusion including the antithetic KEL1 and KEL2; KEL3 and KEL4; KEL6 and KEL7 antigens. Kell is a clinically relevant system, as it is highly immunogenic and anti-KEL antibodies are associated with hemolytic transfusion reactions and hemolytic disease of the fetus and newborn. Although required in some situations, Kell antigen phenotyping is restricted due to technical limitations. In these cases, molecular approaches maybe a solution. This study proposes three polymerase chain reaction genotyping protocols to analyze the single nucleotide polymorphisms responsible for six Kell antithetic antigens expressed in a Brazilian population.

Methods: DNA was extracted from 800 blood donor samples and three polymerase chain reaction-restriction fragment length polymorphism protocols were used to genotype the KEL*1/KEL*2, KEL*3/KEL*4 and KEL*6/KEL*7 alleles. KEL*3/KEL*4 and KEL*6/KEL*7 genotyping was standardized using the NlaIII and MnlI restriction enzymes and validated using sequencing. KEL*1/KEL*2 genotyping was performed using a previously reported assay.

Results: KEL genotyping was successfully implemented in the service; the following distribution of KEL alleles was obtained for a population from southeastern Brazil: KEL*1 (2.2%), KEL*2 (97.8%), KEL*3 (0.69%), KEL*4 (99.31%), KEL*6 (2.69%) and KEL*7 (97.31%). Additionally, two individuals with rare genotypes, KEL*1/KEL*1 and KEL*3/KEL*3, were identified.

Conclusion: KEL allele genotyping using these methods proved to be reliable and applicable to predict Kell antigen expressions in a Brazilian cohort. This easy and efficient strategy can be employed to provide safer transfusions and to help in rare donor screening.

Citing Articles

Genomic analysis of and alleles among Thai blood donors.

Nathalang O, Rassuree P, Intharanut K, Chaibangyang W, Nogues N Afr J Lab Med. 2024; 13(1):2294.

PMID: 38629087 PMC: 11019069. DOI: 10.4102/ajlm.v13i1.2294.


Blood group genotyping in alloimmunized multi-transfused thalassemia patients from Iran.

Sarihi R, Oodi A, Dadkhah Tehrani R, Jalali S, Mardani F, Azarkeivan A Mol Genet Genomic Med. 2021; 9(7):e1701.

PMID: 33963817 PMC: 8372074. DOI: 10.1002/mgg3.1701.


Risk Minimization of Hemolytic Disease of the Fetus and Newborn Using Droplet Digital PCR Method for Accurate Fetal Genotype Assessment of , , and from Cell-Free Fetal DNA of Maternal Plasma.

Vodicka R, Bohmova J, Holuskova I, Krejcirikova E, Prochazka M, Vrtel R Diagnostics (Basel). 2021; 11(5).

PMID: 33925253 PMC: 8146004. DOI: 10.3390/diagnostics11050803.


Genetic variability of blood groups in southern Brazil.

Waskow G, Rodrigues M, Hoher G, Onsten T, Lindenau J, Fiegenbaum M Genet Mol Biol. 2020; 43(2):e20180327.

PMID: 32478792 PMC: 7263432. DOI: 10.1590/1678-4685-GMB-2018-0327.


Clinical Significance of an Alloantibody against the Kell Blood Group Glycoprotein.

Mattaloni S, Arnoni C, Cespedes R, Nonaka C, Trucco Boggione C, Lujan Brajovich M Transfus Med Hemother. 2017; 44(1):53-57.

PMID: 28275334 PMC: 5318919. DOI: 10.1159/000448381.


References
1.
Reid M, Rios M, Powell V, Charles-Pierre D, Malavade V . DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion. 2000; 40(1):48-53. DOI: 10.1046/j.1537-2995.2000.40010048.x. View

2.
Santos N, Ribeiro-Rodrigues E, Ribeiro-Dos-Santos A, Pereira R, Gusmao L, Amorim A . Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel. Hum Mutat. 2009; 31(2):184-90. DOI: 10.1002/humu.21159. View

3.
Jungbauer C . Routine use of DNA testing for red cell antigens in blood centres. Transfus Apher Sci. 2011; 45(1):61-8. DOI: 10.1016/j.transci.2011.06.004. View

4.
Lee S, Zambas E, Green E, Redman C . Organization of the gene encoding the human Kell blood group protein. Blood. 1995; 85(5):1364-70. View

5.
Renoud K, Barracchini K, Byrne K, Adams S, Pickett A, Caruccio L . KEL6 and KEL7 genotyping with sequence-specific primers. Transfusion. 2006; 46(9):1510-4. DOI: 10.1111/j.1537-2995.2006.00937.x. View